BIOMAT Database Logo BIOMAT Database Logo

[Effect of complamine on various indicators of hemostasis and microcirculation in chronic ischemic heart disease]. 1978

R M Bol'shakova, and M A Dukhina, and N K Furkalo, and K M Solovtsova, and V V Progonnaia

UI MeSH Term Description Entries
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R M Bol'shakova, and M A Dukhina, and N K Furkalo, and K M Solovtsova, and V V Progonnaia
[Erythrocytic hemostasis and microcirculation in patients with chronic ischemic heart disease].
March 1985, Vrachebnoe delo,
R M Bol'shakova, and M A Dukhina, and N K Furkalo, and K M Solovtsova, and V V Progonnaia
[Therapeutic effect of complamine in atherosclerosis and ischemic heart disease].
January 1976, Sovetskaia meditsina,
R M Bol'shakova, and M A Dukhina, and N K Furkalo, and K M Solovtsova, and V V Progonnaia
[Effect of needle reflexotherapy on microcirculation, plasma and platelet hemostasis in ischemic heart disease patients].
January 1982, Sovetskaia meditsina,
R M Bol'shakova, and M A Dukhina, and N K Furkalo, and K M Solovtsova, and V V Progonnaia
[Treatment of ischemic heart disease with complamine].
January 1981, Vrachebnoe delo,
R M Bol'shakova, and M A Dukhina, and N K Furkalo, and K M Solovtsova, and V V Progonnaia
[Microcirculation in chronic ischemic heart disease and the effects of nitroglycerin on microcirculation].
January 1980, Terapevticheskii arkhiv,
R M Bol'shakova, and M A Dukhina, and N K Furkalo, and K M Solovtsova, and V V Progonnaia
[Effect of miscleron on various indicators of blood coagulation in ischemic heart disease].
March 1977, Kardiologiia,
R M Bol'shakova, and M A Dukhina, and N K Furkalo, and K M Solovtsova, and V V Progonnaia
[Effect of riboxin on hemodynamics and microcirculation in patients with chronic ischemic heart disease].
January 1983, Vrachebnoe delo,
R M Bol'shakova, and M A Dukhina, and N K Furkalo, and K M Solovtsova, and V V Progonnaia
[Microcirculation and erythrocytic hemostasis in persons with risk factors for ischemic heart disease].
July 1984, Vrachebnoe delo,
R M Bol'shakova, and M A Dukhina, and N K Furkalo, and K M Solovtsova, and V V Progonnaia
[Effect of heparin on certain biochemical and instrumental indicators in chronic ischemic heart disease].
September 1975, Vrachebnoe delo,
R M Bol'shakova, and M A Dukhina, and N K Furkalo, and K M Solovtsova, and V V Progonnaia
[Effect of curantyl on hemostasis and rheological properties of the blood in chronic ischemic heart disease].
January 1981, Sovetskaia meditsina,
Copied contents to your clipboard!